Preferred Label : Early Stage Breast Carcinoma;
NCIt synonyms : Early-Stage Breast Carcinoma;
NCIt related terms : early-stage breast cancer;
NCIt definition : Breast carcinoma that has not spread beyond the breast and the axillary lymph nodes.;
Neoplastic status : Malignant;
Codes from synonyms : CDR0000446564;
Origin ID : C94774;
UMLS CUI : C2986665;
CISMeF manual mappings
- Disease excludes abnormal cell
- Has associated anatomic sites
- Manual BTNT mappings - CISMeF
- Semantic type(s)
- UMLS correspondences (same concept)
- concept_is_in_subset
- disease_excludes_finding
- disease_has_abnormal_cell
- disease_has_finding
- disease_has_normal_cell_origin
- disease_has_normal_tissue_origin
- disease_has_primary_anatomic_site
- disease_is_stage
https://www.has-sante.fr/jcms/p_3471037/fr/
2024
France
health technology assessment
genome, nos
Early Stage Breast Carcinoma
breast cancer
Useful
hospitals, proprietary
Clinical Data
Signature
Genome
early
Clinical Lot
breast neoplasms
Ambulatory Care Facility
neoplasm staging
genomics
Clinical Batch
genome
neoplasm, malignant
---
https://www.cochrane.org/fr/CD014805/BREASTCA_chimiotherapie-contenant-du-platine-pour-les-femmes-avant-ou-apres-une-intervention-chirurgicale
2023
United Kingdom
review of literature
french abstract
Negative Lymph Node
FGFR1 Gene Mutation Negative
GNA11 Gene Mutation Negative
Pharmacotherapy
ERBB2 Gene Amplification Negative
PAS Negative
Cancer Intervention
ERG Gene Rearrangement Negative
Hepatitis B Virus Core Antibody Negative
neoplasm staging
KIT Negative
women
Woman
Hepatitis B Surface Antibody Negative
platinum, nos
SDHB Negative
neoplasm, malignant
Cisplatin
ANO1 Negative
Polypodium leucotomos Extract
ERBB2 Gene Mutation Negative
platinum
Unmethylated MGMT Gene Promoter
FGFR3 Gene Mutation Negative
Lack of Expression of PD-L1
procedural approach, nos
Contain
FGFR2 Gene Mutation Negative
HRAS Gene Mutation Negative
BAP1 Gene Mutation Negative
Carboplatin
NRAS Gene Mutation Negative
operative procedure, nos
Progesterone Receptor Negative
Chemotherapy
Wnt Negative
KRAS Gene Mutation Negative
triplets
FGFR3 Gene Rearrangement Negative
CDKN2A-p16 Negative
Human Immunodeficiency Virus Negative
PAX8 Gene Rearrangement Negative
Drug Therapy
During or After
CTNNB1 Gene Mutation Negative
FGFR2 Gene Rearrangement Negative
GNAQ Gene Mutation Negative
early
RET Gene Rearrangement Negative
Status Post
Negative Number
ATRX Gene Mutation Negative
Have Not Tried It
1p/19q Codeletion Negative
ESR2 Negative
breast cancer
Surgical Procedure
Epstein-Barr Virus Negative
chemotherapy
10q23/PTEN Locus Deletion Negative
Platinum
SDHA Negative
triple negative breast neoplasms
Negative Charge
Hepatitis B Virus Surface Antigen Negative
TERT Promoter Mutation Negative
BRAF Gene Mutation Negative
Early Stage Breast Carcinoma
ETV Gene Rearrangement Negative
surgical procedures, operative
IDH Family Wildtype
chemotherapy, nos
Succimer
Platinum Eskimo
CDH1 Gene Mutation Negative
---
https://www.has-sante.fr/jcms/p_3471037/fr/actualisation-2023-utilite-clinique-des-signatures-genomiques-dans-le-cancer-du-sein-rh-/her2-de-stade-precoce
2023
France
health technology assessment
neoplasm staging
Clinical Batch
Medical Examination
early
genome
breast cancer
Clinical Lot
technology assessment
genomics
Early Stage Breast Carcinoma
Genome
Clinical Data
hospitals, proprietary
health
Ambulatory Care Facility
Technology Assessment
neoplasm, malignant
genome, nos
technology assessment, biomedical
breast neoplasms
Signature
Useful
---
https://www.cochrane.org/fr/CD013167/BREASTCA_therapies-systemiques-dans-la-prevention-ou-le-traitement-des-symptomes-musculo-squelettiques
2022
false
false
false
United Kingdom
Early Stage Breast Carcinoma
signs and symptoms
Systemic Therapy
musculoskeletal pain
musculoskeletal pain
aromatase inhibitors
review of literature
french abstract
aromatase inhibitors
neoplasm staging
breast neoplasms
---
